APA (7th ed.) Citation

Lin, Z., Yang, Y., Liu, T., Wu, Z., Zhang, X., & Yang, J. (2024). Germacrone alleviates breast cancer‐associated osteolysis by inhibiting osteoclastogenesis via inhibition of MAPK/NF‐κB signaling pathways. Wiley. https://doi.org/10.1002/ptr.8195

Chicago Style (17th ed.) Citation

Lin, Zhengjun, Yaocheng Yang, Tang Liu, Ziyi Wu, Xianghong Zhang, and Jing Yang. Germacrone Alleviates Breast Cancer‐associated Osteolysis by Inhibiting Osteoclastogenesis via Inhibition of MAPK/NF‐κB Signaling Pathways. Wiley, 2024. https://doi.org/10.1002/ptr.8195.

MLA (9th ed.) Citation

Lin, Zhengjun, et al. Germacrone Alleviates Breast Cancer‐associated Osteolysis by Inhibiting Osteoclastogenesis via Inhibition of MAPK/NF‐κB Signaling Pathways. Wiley, 2024. https://doi.org/10.1002/ptr.8195.